Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.

Opis bibliograficzny
Główni autorzy:	Hennekens, C, Buring, J, Sandercock, P, Collins, R, Peto, R
Format:	Journal article
Język:	English
Wydane:	1989

Podobne zapisy

Aspirin and stroke.
od: Buring, J, i wsp.
Wydane: (1990)

ASPIRIN USE AND CHRONIC DISEASES
od: Hennekens, C, i wsp.
Wydane: (1990)

Aspirin in ischemic heart disease.
od: Hennekens, C, i wsp.
Wydane: (1992)

Low-dose aspirin for migraine prophylaxis.
od: Buring, J, i wsp.
Wydane: (1990)

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
od: Baigent, C, i wsp.
Wydane: (2009)

Antioxidant vitamins, cancer, and cardiovascular disease - Reply
od: Hennekens, C, i wsp.
Wydane: (1996)

Antiplatelet agents in stroke prevention.
od: Peto, R
Wydane: (1988)

Aspirin in the primary prevention of vascular disease Reply
od: Baigent, C, i wsp.
Wydane: (2009)

Aspirin in the primary prevention of vascular disease Reply
od: Baigent, C, i wsp.
Wydane: (2009)

Prevention. Aspirin in primary prevention--good news and bad news.
od: Hennekens, C, i wsp.
Wydane: (2012)

Prevention: Aspirin in primary prevention-good news and bad news
od: Hennekens, C, i wsp.
Wydane: (2012)

Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration.
od: Collins, R, i wsp.
Wydane: (1994)

TRIALS OF ANTIPLATELET THERAPY - REPLY
od: Baigent, C, i wsp.
Wydane: (1994)

Polypills with or without aspirin for primary prevention of cardiovascular disease
od: Mant, J, i wsp.
Wydane: (2021)

Role of aspirin in primary prevention of cardiovascular disease
od: Patrono, C, i wsp.
Wydane: (2019)

Aspirin overutilization for the primary prevention of cardiovascular disease
od: VanWormer JJ, i wsp.
Wydane: (2014-12-01)

Aspirin for primary prevention of cardiovascular disease in diabetes
od: Ying Xing, i wsp.
Wydane: (2019-07-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
Wydane: (2005-12-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
od: Randall S Stafford, i wsp.
Wydane: (2005-12-01)

Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease
od: Guillaume Marquis‐Gravel, i wsp.
Wydane: (2024-02-01)

An overview of the British and American aspirin studies.
od: Hennekens, C, i wsp.
Wydane: (1988)

Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesis.
od: Hennekens, C, i wsp.
Wydane: (2006)

PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE AND ANTIPLATELET THERAPY. CLINICAL LECTURE
od: L. O. Minushkina
Wydane: (2017-12-01)

Which people should take aspirin for primary prevention of cardiovascular disease?
od: Lozano R, i wsp.
Wydane: (2015-07-01)

Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
od: Yinong Chen, i wsp.
Wydane: (2021-09-01)

Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain
od: Fernández-de-Bobadilla Jaime, i wsp.
Wydane: (2007-10-01)

Use and Misuse of Aspirin in Primary Cardiovascular Prevention
od: Sergio Coccheri
Wydane: (2017-04-01)

Antiplatelet treatment in primary and secondary stroke prevention in women.
od: Caso, V, i wsp.
Wydane: (2012)

Antiplatelet treatment in primary and secondary stroke prevention in women
od: Caso, V, i wsp.
Wydane: (2012)

Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018
od: Mikkel B. Christensen, i wsp.
Wydane: (2021-06-01)

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
od: Price, H, i wsp.
Wydane: (2009)

Aspirin for prevention of cancer and cardiovascular disease.
od: Rose, P, i wsp.
Wydane: (2011)

Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
od: Patrono, C, i wsp.
Wydane: (2010)

Aspirin strategy for secondary prevention of atherosclerotic cardiovascular diseases: A narrative review
od: Nischal N Hegde, i wsp.
Wydane: (2023-01-01)

Role of aspirin in the primary prevention of cardiovascular disease in patients with hyperlipoproteinaemia(a)
od: Eleni Giannopoulou, i wsp.
Wydane: (2024-12-01)

US population qualifying for aspirin use for primary prevention of cardiovascular disease
od: Athena L. Huang, i wsp.
Wydane: (2024-06-01)

US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:
od: Athena L. Huang, MD, i wsp.
Wydane: (2023-09-01)

DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT
od: N. В. Perepech, i wsp.
Wydane: (2018-05-01)

Antiplatelets in secondary stroke prevention
od: Olga eShulga, i wsp.
Wydane: (2011-07-01)

Antioxidant vitamins--benefits not yet proved.
od: Hennekens, C, i wsp.
Wydane: (1994)